Ten years of experience with therapeutic justice in Brazil
DOI:
https://doi.org/10.25118/2763-9037.2024.v14.1192Keywords:
therapeutic justice, outpatient clinic hospital, public prosecutor's office, psychiatry, mental health, drugs dependency, harmful use, alcohol, ethanol, cannabis, marijuana, cocaine, crack, drugsAbstract
Introduction: Therapeutic Justice (TJ) emerged in the United States in 1989 to reduce the prison population associated with drug-related crimes. Focused on the rehabilitation and treatment of offenders, TJ holds promising potential for reducing recidivism and facilitating social reintegration, thereby alleviating prison overcrowding and reducing the demand on the judiciary. In Brazil, it began in Rio Grande do Sul in 2000 and in São Paulo in 2002. Objective: Describe the construction of Project TJ by the Public Prosecutor's Office of the State of São Paulo and its partnership with the Medical Outpatient Specialty Clinic in Psychiatry, Dr. Jandira Masur (AME Psychiatry), under the management of the São Paulo Association for the Development of Medicine (SPDM), providing data on the profile and outcome of 150 patients referred by the TJ to the AME Psychiatry from March 2012 to December 2022. Methodology: Descriptive cross-sectional study with data from 150 authors of offenses referred by the Public Prosecutor's Office to AME Psychiatry in the TJ Program between March 2012 and December 2022. Results: Of those referred who accepted the proposal of penal transaction or conditional suspension of the process, 59.80% fully complied with the benefit. The majority (49%) had a disorder related to alcohol use, followed by cannabis-related disorder (17%) and cocaine or crack-related disorder (10%). 14% were not evaluated and 2% did not have a diagnosis according to ICD-10. Conclusion: The partnership between the Public Prosecutor's Office and the AME Psychiatry in the northern zone of São Paulo has enabled access to treatment for offenders with mental disorders related to the use of alcohol and other drugs. The ten-year experience of this collaboration suggests a replicable model for other regions, even with limited financial resources, demonstrating the sustainability of the TJ Program. This practical description can support future studies that demonstrate the program's efficacy in Brazil.
Downloads
Metrics
References
Nolan JL Jr. Drug treatment courts and the disease paradigm. Subst Use Misuse. 2002;37(12-13):1723-50. https://doi.org/10.1081/ja-120014428 - PMID:12487240 DOI: https://doi.org/10.1081/JA-120014428
Castro TC. A utilização da justiça terapêutica no tratamento dos adolescentes infratores envolvidos com drogas [trabalho de conclusão de curso]. Fortaleza: Universidade de Fortaleza; 2003.
Brasil. Lei nº 9.099, de 26 de setembro de 1995. Dispõe sobre os Juizados Especiais Cíveis e Criminais e dá outras providências. http://www.planalto.gov.br/ccivil_03/LEIS/L9099.htm
Brasil. Lei nº 11.343, de 23 de agosto de 2006. Institui o Sistema Nacional de Políticas Públicas sobre Drogas - Sisnad; prescreve medidas para prevenção do uso indevido, atenção e reinserção social de usuários e dependentes de drogas; estabelece normas para repressão à produção não autorizada e ao tráfico ilícito de drogas; define crimes e dá outras providências. http://www.planalto.gov.br/ccivil_03/_ato2004-2006/2006/lei/l11343.htm
Brasil. Lei nº 9.503, de 23 de setembro de 1997. Institui o Código de Trânsito Brasileiro. http://www.planalto.gov.br/ccivil_03/leis/l9503compilado.htm
Santos AHG, Bortolon CB, Amino D, Laranjeira R. Ambulatório médico de psiquiatria: 30.151 casos. Debates Psiquiatr. 2020;10(3):16-22. https://doi.org/10.25118/2763-9037.2020.v10.25 DOI: https://doi.org/10.25118/2763-9037.2020.v10.25
Brasil. Lei nº 10.216, de 6 de abril de 2001. Dispõe sobre a proteção e os direitos das pessoas portadoras de transtornos mentais e redireciona o modelo assistencial em saúde mental. https://www.planalto.gov.br/ccivil_03/leis/leis_2001/l10216.htm
Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O'Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK; Mat Working Group Of CJ-Dats. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus. 2012;33(1):9-18. https://doi.org/10.1080/08897077.2011.611460 - PMID:22263709 PMCID:PMC3295578 DOI: https://doi.org/10.1080/08897077.2011.611460
Dickson-Gomez J, Spector A, Krechel S, Li J, Montaque HDG, Ohlrich J, Galletly C, Weeks M. Barriers to drug treatment in police diversion programs and drug courts: A qualitative analysis. Am J Orthopsychiatry. 2022;92(6):692-701. https://doi.org/10.1037/ort0000643 - PMID:36227322 PMCID:PMC9993933 DOI: https://doi.org/10.1037/ort0000643
Organização Pan-Americana da Saúde. Série de fichas técnicas sobre álcool e saúde. Washington: Organização Pan-Americana da Saúde; 2023. https://www.paho.org/pt/serie-fichas-tecnicas-sobre-alcool-e-saude
Leyton V, Greve JMD, Carvalho DG, Muñoz DR. Perfil epidemiológico das vítimas fatais por acidente de trânsito e a relação com o uso do álcool. Saúde Ética Justiça. 2005;10(1-2):12-8. https://doi.org/10.11606/issn.2317-2770.v10i1-2p12-18 DOI: https://doi.org/10.11606/issn.2317-2770.v10i1-2p12-18
Carvalho CHR. Custos dos acidentes de trânsito no Brasil: estimativa simplificada com base na atualização das pesquisas do IPEA sobre custos de acidentes nos aglomerados urbanos e rodovias. Brasília: IPEA; 2020. Texto para discussão 2565. https://www.ipea.gov.br/atlasviolencia/arquivos/artigos/7018-td2565.pdf
Schwartz JR, Schwartz LP. The drug court: a new strategy for drug use prevention. Obstet Gynecol Clin North Am. 1998;25(1):255-68. https://doi.org/10.1016/S0889-8545(05)70368-5 DOI: https://doi.org/10.1016/S0889-8545(05)70368-5
Stein DM, Deberard S, Homan K. Predicting success and failure in juvenile drug treatment court: a meta-analytic review. J Subst Abuse Treat. 2013;44(2):159-68. https://doi.org/10.1016/j.jsat.2012.07.002 - PMID:22980448 DOI: https://doi.org/10.1016/j.jsat.2012.07.002
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ariella Hasegawa Galvão Santos, Mário Sérgio Sobrinho, Rodney Clayde Bolsone Elias da Silva, Francisco Xavier Pauliquevis de Almeida Prado, Patricia Takesaki Miyaji Naricawa, Pedro Ferreira Leite Neto, Ronaldo Ramos Laranjeira
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
